v3.26.1
Research and Development Expense (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 02, 2026
Aug. 11, 2025
Jun. 03, 2025
Mar. 31, 2025
Jan. 17, 2025
Dec. 20, 2024
Oct. 09, 2024
Sep. 07, 2023
Apr. 30, 2026
Jul. 31, 2025
Jun. 30, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Aug. 12, 2025
Mar. 30, 2025
Apr. 20, 2024
Mar. 20, 2024
Proceeds from Issuance of Common Stock                             $ 355,000 $ 11,948,000 $ 19,699,000 $ 3,328,000        
General and Administrative Expense                     $ 2,700,000   $ 3,092,000   5,578,000 5,792,000 31,703,000 12,041,000        
Research and Development Expense                     302,000   1,860,000   1,080,000 2,776,000 5,054,000 3,378,000        
Issuance of Common Stock for licensing right                                   1,568,000        
Amortization                             621,000 739,000 1,440,000 1,666,000        
Prepaid Expense                                   400,000        
Agreement related expense                                 6,000 20,000        
Issuance of common stock services                         740,000   530,000 2,952,000 1,152,000 $ 242,000        
Share Price                                     $ 3,480   $ 9,359,532 $ 10,394,480
Sarborg Limited [Member]                                            
Research and Development Expense                     100,000   1,600,000   600,000 2,400,000 4,200,000          
Cash payment                                 300,000          
Agreement related expense                           400,000              
Issuance of common stock services                   $ 300,000                        
Remaining debt                                 300,000          
Equity consideration received per transaction                       $ 200,000                    
Payment of Financing and Stock Issuance Costs   $ 200,000                                        
Other Intangible Assets, Net   $ 600,000                                        
Common Stock [Member]                                            
Shares issued             1 2                   4        
Issuance of Common Stock for licensing right             $ 80,000   $ 100,000                        
Issuance of common stock services                                  
Common Stock [Member] | Sarborg Limited [Member]                                            
Consideration payable $ 400,000                                          
Common Stock [Member] | Second Additional Agreement [Member]                                            
Consideration payable $ 200,000                                          
SARBORG Service Agreement [Member]                                            
Shares issued                                 1          
Research and Development Expense                                 $ 2,200,000          
Cash payment         $ 200,000 $ 200,000                 200,000   200,000          
Repayments of Other Debt                                 1,800,000          
Amortization                         100,000     200,000 400,000 200,000        
Prepaid Expense                                 400,000        
Agreement related expense                         500,000     1,200,000 1,800,000          
Diagnostic asset                                 $ 400,000          
Payable in cash                     1,800,000       $ 1,800,000              
SARBORG Service Agreement [Member] | Common Stock [Member]                                            
Shares issued         1                   1   1          
Issuance of Common Stock for licensing right                             $ 200,000   $ 200,000          
Service Agreement [Member]                                            
Amortization                     100,000   100,000   100,000 100,000 200,000          
Intangible assets current                     400,000       400,000   400,000          
SARBORG Additional Agreement [Member]                                            
Research and Development Expense                                 1,300,000          
Cash payment       $ 2,000,000.0                                    
Amortization                     $ 100,000   $ 400,000   $ 200,000 $ 400,000            
Prepaid Expense       $ 1,650,000                   $ 1,650,000                
Shares Issued, Price Per Share                                       $ 26,698.70    
Fair value of asset acquired                           $ 1,500,000     1,500,000          
SARBORG Additional Agreement [Member] | Reverse Stock Split [Member]                                            
Shares Issued, Price Per Share                                       $ 26,698.70    
SARBORG Additional Agreement [Member] | Common Stock [Member]                                            
Shares issued       62                                    
SARBORG Additional Agreement [Member] | Common Stock [Member] | Reverse Stock Split [Member]                                            
Shares issued       61                                    
SARBORG Additional Service Agreement [Member]                                            
Prepaid Expense                                 600,000          
Manoira Joint Development Agreement [Member]                                            
Amortization                                 100,000          
Fair value of asset acquired     $ 400,000                                      
Manoira Joint Development Agreement [Member] | Common Stock [Member]                                            
Shares issued     77                                      
Issuance of Common Stock for licensing right     $ 500,000                                      
Shares Issued, Price Per Share     $ 6,460                                      
Share Price     $ 6,460                                      
Manoira Joint Development Agreement [Member] | Common Stock [Member] | Reverse Stock Split [Member]                                            
Shares issued     77                                      
Astra Zeneca [Member]                                            
Proceeds from Issuance of Common Stock                                 $ 1,500,000          
Shares issued                                 3          
General and Administrative Expense                                   1,600,000        
Research and Development Expense                                   $ 1,500,000